N-α-Fmoc-N-ω-2,2,5,7,8-pentamethylchroman

N-α-Fmoc-N-ω-2,2,5,7,8-pentamethylchroman is an Fmoc-protected amino acid derivative in which the nitrogen bears an α-Fmoc carbamate and the ω-position is substituted with a 2,2,5,7,8-pentamethylchroman side-chain. The molecule combines a protected amine suitable for stepwise peptide assembly with a bulky, hydrophobic chroman motif that can modulate conformation, polarity, and steric presentation in downstream constructs. The Fmoc group provides orthogonal protection for N-terminal peptide coupling, while the chroman substituent introduces an aromatic/heterocycle-like ring system with multiple methyl substituents that can participate in hydrophobic and π-associated interactions. The resulting chiral amino acid intermediate can be employed as a protected building block for preparing peptide analogs, chiral side-chain variants, and functionalized intermediates for synthetic organic chemistry and applied materials research.

1. Peptide Synthesis

N-α-Fmoc-N-ω-2,2,5,7,8-pentamethylchroman serves as a protected amino acid building block for solid-phase or solution-phase peptide synthesis where Fmoc deprotection enables controlled N-terminal activation and coupling. The α-Fmoc carbamate protects the amino functionality during chain elongation, while the ω-chroman substituent provides a hydrophobic side-chain handle that can be carried into peptide backbones to generate amphiphilic balance and steric bias. The protected amine can be converted into peptide bonds using standard peptide coupling chemistries compatible with Fmoc strategies, supporting incorporation into sequence-defined peptides and peptidomimetics. Downstream constructs may be used to probe side-chain effects on folding propensity, binding-site complementarity, and conformational preferences in peptide science and chemical biology.

2. Peptidomimetics And SAR Studies

N-α-Fmoc-N-ω-2,2,5,7,8-pentamethylchroman is suitable for peptidomimetic construction and structure-activity relationship studies where a chroman-bearing side chain acts as a conformationally and sterically informative substituent. The pentamethylchroman moiety increases hydrophobic character and can influence local packing, while the protected amino acid framework supports systematic substitution at defined positions within peptide-like scaffolds. Fmoc-based incorporation allows rapid generation of analog series that vary only in side-chain placement or neighboring residue identity, supporting SAR workflows that rely on consistent synthetic handles. The resulting peptide analogs can then be used as molecular probes in biochemical research intermediate preparation and in downstream assay-compatible material generation.

3. Side-Chain Functionalization

N-α-Fmoc-N-ω-2,2,5,7,8-pentamethylchroman can be applied to side-chain functionalization strategies that leverage the chroman ring as a stable hydrophobic scaffold during synthetic elaboration. The presence of multiple methyl substituents and the fused ring topology can direct functional-group tolerance by reducing unwanted side reactions at the aromatic core while maintaining a distinct steric environment for subsequent transformations. The Fmoc-protected nitrogen enables orthogonal deprotection and selective downstream chemistry at the peptide level, allowing conversion into amino acid derivatives, macrocyclization precursors, or conjugation-ready intermediates after peptide fragment assembly. The chroman-containing side chain can also serve as a fragment in fragment-based molecular design and medicinal chemistry intermediate preparation where hydrophobic pharmacophore mimicry is required.

4. Chemical Biology Probes

N-α-Fmoc-N-ω-2,2,5,7,8-pentamethylchroman is applicable to chemical biology workflows that require incorporation of hydrophobic, ring-containing side chains into sequence-defined probes. The α-Fmoc protection supports stepwise assembly of labeled or functionalized peptide fragments, while the pentamethylchroman motif can improve membrane association propensity or stabilize probe conformation through hydrophobic packing. The resulting constructs can be used as biochemical research intermediates for generating receptor-binding probes, enzyme-interaction mimics, or scaffold variants used to map binding-site preferences. The compound's protected amino acid nature also supports compatibility with orthogonal deprotection and subsequent conjugation steps that generate assay-ready biomolecular reagents.

5. Pharmaceutical Intermediate Preparation

N-α-Fmoc-N-ω-2,2,5,7,8-pentamethylchroman can be employed in pharmaceutical intermediate preparation for manufacturing routes that synthesize peptide-based actives or peptide-like intermediates requiring protected amino acid inputs. The Fmoc-protected amine aligns with established protected amino acid chemistry, enabling controlled coupling sequences and minimizing side reactions during intermediate isolation. The chroman side chain contributes a defined hydrophobic fragment that can be carried through to later-stage derivatization, such as salt formation, formulation-compatible modifications, or further functional group installation on assembled fragments. The compound therefore functions as a chiral amino acid intermediate for fine chemical synthesis where reproducible protection/deprotection logic and peptide coupling compatibility are required for scalable production of defined molecular entities.

6. Process Chemistry Intermediate

N-α-Fmoc-N-ω-2,2,5,7,8-pentamethylchroman is relevant to process chemistry intermediate development where protected amino acid derivatives must withstand coupling conditions and purification steps without premature deprotection. The Fmoc carbamate provides a predictable protection strategy for N-terminus management, while the bulky pentamethylchroman substituent can influence solubility and crystallization behavior of downstream intermediates, which may be leveraged during manufacturing route design. The compound's structure supports incorporation into peptide fragments that can be further processed into higher-molecular-weight intermediates, enabling modular assembly of complex scaffolds in specialty chemical production. The chroman-containing protected amino acid thus supports industrially oriented synthetic planning that relies on orthogonal protection, robust peptide coupling compatibility, and controlled downstream derivatization pathways.

1. Therapeutic potential of an intestinotrophic hormone, glucagon-like peptide 2, for treatment of type 2 short bowel syndrome rats with intestinal bacterial and fungal dysbiosis

2. C-peptide and its C-terminal fragments improve erythrocyte deformability in type 1 diabetes patients

3. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate

4. Characterization of Novel P-Selectin Targeted Complement Inhibitors in Murine Models of Hindlimb Injury and Transplantation

5. The effect of sex on immune responses to a homocitrullinated peptide in the DR4-transgenic mouse model of Rheumatoid Arthritis